List view / Grid view
29 December 2011 | By Janssen Research & Development, LLC
Janssen Research & Development, LLC (JRD) have announced that it has submitted a sNDA to the FDA seeking approval for the use of XARELTO® (rivaroxaban)...
27 December 2011 | By ICON plc
ICON plc., has announced the retirement of Non-Executive Director, Dr. Anthony Murphy to become effective on 31st December 2011...
20 December 2011 | By Bayer HealthCare
The only new oral anticoagulant approved in three indications across all 27 EU member states...
20 December 2011 | By Alkermes
ALKS 9070 is designed to offer once-monthly version of Aripiprazole...
20 December 2011 | By AstraZeneca
With associated impairment charges, company confirms full year financial target...
19 December 2011 | By Roche
For the treatment of people with BRAF mutation-positive metastatic melanoma...
19 December 2011 | By Pfizer
Patients with Restless Legs Syndrome (RLS) show significant benefit...
19 December 2011 | By GlaxoSmithKline
Move aims to protect millions more children in the world's poorest countries from pneumococcal disease...
19 December 2011 | By Amgen
Kevin W. Sharer has announced his plan to retire from the Company at the end of 2012...
15 December 2011 | By
The companies have expanded the strategic partnership formed last year...
15 December 2011 | By Bayer HealthCare
Once approved, the new low dose IUS will offer contraception for up to three years...
15 December 2011 | By Amgen
Additional key Nplate (Romiplostim) data also presented at American Society of Hematology annual meeting...
15 December 2011 | By Merck
New clinical trial will evaluate an investigational therapeutic regimen with VICTRELIS™ (boceprevir)...
15 December 2011 | By Roche
Roche announced that Sophie Kornowski-Bonnet has been appointed Head of Roche Partnering...
15 December 2011 | By Novartis
Once-daily oral MS medicine showed a 48% relative reduction in annualized relapse rate, meeting primary endpoint in Phase III placebo-controlled study...
